UniSa - IRIS Institutional Research Information System

ERRO, Roberto
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 17.871
NA - Nord America 12.855
EU - Europa 4.865
SA - Sud America 2.045
Continente sconosciuto - Info sul continente non disponibili 625
AF - Africa 210
OC - Oceania 67
Totale 38.538
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 12.437
HK - Hong Kong 11.524
SG - Singapore 2.759
IT - Italia 2.237
BR - Brasile 1.560
CN - Cina 1.167
VN - Vietnam 1.117
RU - Federazione Russa 532
UA - Ucraina 372
IE - Irlanda 319
DE - Germania 315
TR - Turchia 309
FR - Francia 289
KR - Corea 239
CA - Canada 204
SE - Svezia 197
GB - Regno Unito 185
AR - Argentina 183
BD - Bangladesh 159
IN - India 136
MX - Messico 93
ID - Indonesia 89
JP - Giappone 81
EC - Ecuador 79
FI - Finlandia 77
CO - Colombia 73
IQ - Iraq 61
NL - Olanda 58
ZA - Sudafrica 58
PL - Polonia 54
EE - Estonia 42
ES - Italia 40
VE - Venezuela 38
AU - Australia 36
AT - Austria 32
MA - Marocco 32
PK - Pakistan 30
PY - Paraguay 30
CL - Cile 29
NZ - Nuova Zelanda 28
KE - Kenya 25
UZ - Uzbekistan 25
CR - Costa Rica 24
UY - Uruguay 21
EG - Egitto 19
CZ - Repubblica Ceca 18
JM - Giamaica 18
PE - Perù 18
DZ - Algeria 17
JO - Giordania 17
SA - Arabia Saudita 16
PH - Filippine 15
TN - Tunisia 14
MY - Malesia 13
AL - Albania 12
BO - Bolivia 12
LB - Libano 12
NP - Nepal 12
AE - Emirati Arabi Uniti 11
DO - Repubblica Dominicana 11
LT - Lituania 11
NI - Nicaragua 11
AZ - Azerbaigian 10
KZ - Kazakistan 10
HN - Honduras 9
IL - Israele 9
CH - Svizzera 8
GR - Grecia 8
PA - Panama 8
PR - Porto Rico 8
ET - Etiopia 7
IR - Iran 7
SV - El Salvador 7
BE - Belgio 6
CI - Costa d'Avorio 6
GT - Guatemala 6
KW - Kuwait 6
TH - Thailandia 6
BG - Bulgaria 5
HU - Ungheria 5
MD - Moldavia 5
NO - Norvegia 5
OM - Oman 5
RS - Serbia 5
SN - Senegal 5
TT - Trinidad e Tobago 5
BH - Bahrain 4
BY - Bielorussia 4
SK - Slovacchia (Repubblica Slovacca) 4
XK - ???statistics.table.value.countryCode.XK??? 4
CY - Cipro 3
DK - Danimarca 3
GE - Georgia 3
HR - Croazia 3
KG - Kirghizistan 3
MU - Mauritius 3
SI - Slovenia 3
SO - Somalia 3
AM - Armenia 2
BA - Bosnia-Erzegovina 2
Totale 37.857
Salva come PNG Salva come JPEG
Città #
Hong Kong 11.510
San Jose 1.792
Singapore 1.335
Ann Arbor 1.219
Milan 905
Princeton 849
Ashburn 768
Dallas 723
Council Bluffs 632
Chandler 539
Wilmington 498
Jacksonville 437
Ho Chi Minh City 357
Beijing 311
Dublin 309
The Dalles 276
Izmir 265
Lauterbourg 255
Rome 219
Houston 218
Woodbridge 216
New York 208
Hanoi 206
Los Angeles 202
Salerno 187
Santa Clara 179
Dong Ket 162
Moscow 155
São Paulo 138
Andover 127
Naples 126
Pellezzano 121
Nanjing 115
Figino 93
Phoenix 92
Norwalk 73
Tokyo 73
Boardman 69
Chicago 64
Fairfield 62
Buffalo 57
Frankfurt am Main 57
Munich 53
Rio de Janeiro 50
Orem 49
Nuremberg 48
Da Nang 47
Denver 46
Haiphong 46
Montreal 46
Turin 46
Brooklyn 45
Atlanta 44
Düsseldorf 44
Shenyang 44
San Francisco 43
Warsaw 43
Brasília 42
Toronto 39
Pune 38
Boston 37
Tallinn 37
Hebei 36
Curitiba 35
Nanchang 34
Changsha 33
Columbus 33
London 30
Seattle 30
Belo Horizonte 29
Dearborn 29
San Diego 29
Seoul 29
Johannesburg 28
Mexico City 28
Mestre 27
Stockholm 27
Washington 27
West Jordan 27
Amsterdam 26
Jiaxing 26
Baghdad 25
Guayaquil 25
Quito 24
Tashkent 24
Nairobi 23
Philadelphia 23
Porto Alegre 23
Bologna 22
Fortaleza 22
Redwood City 22
Guarulhos 21
Turku 20
Salvador 19
Uberlândia 19
San José 18
Thái Bình 18
Guangzhou 17
Las Vegas 17
Medellín 17
Totale 28.048
Salva come PNG Salva come JPEG
Nome #
Retinal thinning in progressive supranuclear palsy: differences with healthy controls and correlation with clinical variables 1.217
Longitudinal change of energy expenditure, body composition and dietary habits in Progressive Supranuclear Palsy patients 976
Managing Device-Aided Treatments in Parkinson's Disease in Times of COVID-19 945
Sex Differences in Parkinson’s Disease: From Bench to Bedside 657
Insulin-like growth factor-1 predicts cognitive functions at 2-year follow-up in early, drug-naïve Parkinson's disease. 553
Increased glucosylsphingosine levels and Gaucher disease in GBA1-associated Parkinson's disease 553
Gait Analysis in Progressive Supranuclear Palsy Phenotypes. 551
Relationship Between Orthostatic Hypotension and Cognitive Functions in Multiple System Atrophy: A Longitudinal Study 541
Combined regional T1w/T2w ratio and voxel-based morphometry in multiple system atrophy: A follow-up study 525
Psychometric properties of the Beck Depression Inventory-II in progressive supranuclear palsy 487
Quality of Life and Nonmotor Symptoms in Parkinson's Disease 477
White matter changes and the development of motor phenotypes in de novo Parkinson's Disease 466
Motor and Sensory Features of Cervical Dystonia Subtypes: Data From the Italian Dystonia Registry 456
Fist-Palm Test May Identify Mild Cognitive Impairment and Freezing of Gait in Parkinson's Disease: A Machine Learning Approach 413
Energy expenditure, body composition and dietary habits in progressive supranuclear palsy 403
Fist-Palm Test (FiPaT): a bedside motor tool to screen for global cognitive status 402
Remission in dystonia – Systematic review of the literature and meta-analysis 381
Non-invasive brain stimulation for dystonia: therapeutic implications 369
Apathy evaluation scale-informant version in progressive supranuclear palsy: Psychometric properties and clinical correlates 365
Improving the Efficacy of Botulinum Toxin for Cervical Dystonia: A Scoping Review 355
[¹²³I]FP-CIT SPECT (DaTSCAN) may be a useful tool to differentiate between Parkinson's disease and vascular or drug-induced parkinsonisms: a meta-analysis. 343
Magnetic resonance T1w/T2w ratio and voxel-based morphometry in multiple system atrophy 331
Anxiety is associated with striatal dopamine transporter availability in newly diagnosed untreated Parkinson's disease patients. 285
Hypomorphic NOTCH3 mutation in an Italian family with CADASIL features 256
Intraocular pressure and choroidal thickness postural changes in multiple system atrophy and Parkinson's disease 255
A Bayesian approach to Essential Tremor plus: A preliminary analysis of the TITAN cohort 252
Validation of an Italian version of the 40-item University of Pennsylvania Smell Identification Test that is physician administered: our experience on one hundred and thirty-eight healthy subjects 229
Apathy and striatal dopamine transporter levels in de-novo, untreated Parkinson's disease patients 223
Lower serum uric acid is associated with mild cognitive impairment in early Parkinson's disease: a 4-year follow-up study 219
Validation of the Italian version of carers’ quality-of-life questionnaire for parkinsonism (PQoL Carer) in progressive supranuclear palsy 205
Apathy in untreated, de novo patients with Parkinson’s disease: validation study of Apathy Evaluation Scale 198
A window into the mind-brain-body interplay: Development of diagnostic, prognostic biomarkers, and rehabilitation strategies in functional motor disorders 196
ADCY5 mutations are another cause of benign hereditary chorea 195
Olfaction in Homozygous and Heterozygous SYNJ1 Arg258Gln Mutation Carriers 188
Cognitive performances and DAT imaging in early Parkinson's disease with mild cognitive impairment: a preliminary study 177
A Four-Year Longitudinal Study on Restless Legs Syndrome in Parkinson Disease 177
Neuropsychological correlates of Pisa syndrome in patients with Parkinson's disease 172
Essential tremor plus rest tremor: current concepts and controversies 170
Quitting smoking: An early non-motor feature of Parkinson's disease? 170
Abnormal eating behaviors in progressive supranuclear palsy. 167
A two-year follow-up study of executive dysfunctions in parkinsonian patients with freezing of gait at on-state. 163
Are granular osmiophilic material deposits an epiphenomenon in CADASIL? 163
Cognitive behavioural therapy and adjunctive physical activity for functional movement disorders (Conversion Disorder): A pilot, single-blinded, randomized study 162
Serum uric acid is associated with apathy in early, drug-naïve Parkinson’s disease 161
Association of MRI Measures With Disease Severity and Progression in Progressive Supranuclear Palsy 161
Machine learning can predict mild cognitive impairment in Parkinson's disease 159
Increased bilirubin levels in de novo Parkinson's disease 158
Link between non-motor symptoms and cognitive dysfunctions in de novo, drug-naive PD patients. 154
Mild Cognitive Impairment in newly diagnosed Parkinson's disease: A longitudinal prospective study 154
Association between dopaminergic dysfunction and anxiety in de novo Parkinson's disease 153
Nonmotor predictors for levodopa requirement in de novo patients with Parkinson's disease 150
Caffeine consumption and the 4-year progression of de novo Parkinson's disease 147
The Motor Syndrome of Parkinson's Disease 147
Is serum uric acid related to non-motor symptoms in de-novo Parkinson's disease patients? 146
Spread of dystonia in patients with idiopathic adult-onset laryngeal dystonia 146
Regional gray matter atrophy in patients with Parkinson disease and freezing of gait 145
The heterogeneity of early Parkinson's disease: a cluster analysis on newly diagnosed untreated patients. 145
Toward the premotor diagnosis of Parkinson's disease: Suggestions from a modelling study 142
Diagnosis and treatment of restless legs syndrome in progressive supranuclear palsy 142
Resting-state functional connectivity associated with mild cognitive impairment in Parkinson’s disease 141
Bipolar Disorder and Parkinson’s Disease: A 123I-Ioflupane Dopamine Transporter SPECT Study 141
Affective and cognitive theory of mind in patients with cervical dystonia with and without tremor 140
The non-motor side of the honeymoon period of Parkinson's disease and its relationship with quality of life: A 4-year longitudinal study 137
Gender and non motor fluctuations in Parkinson's disease: A prospective study 134
Cerebellar and brainstem functional abnormalities in patients with primary orthostatic tremor 134
GBA-Related Parkinson's Disease: Dissection of Genotype–Phenotype Correlates in a Large Italian Cohort 133
Regional Gray Matter Atrophy in Patients with Parkinson Disease and Freezing of Gait. 131
Early MRI findings in acquired hepatocerebral degeneration. 130
Malabsorption is uncommon in restless legs syndrome. 129
Dopamine transporter availability in motor subtypes of de novo drug-naïve Parkinson’s disease 129
MDS PSP criteria in real-life clinical setting: Motor and cognitive characterization of subtypes 128
Effects of gender on cognitive and behavioral manifestations in multiple system atrophy 128
Impact of COVID-19 on neurological patients attending a botulinum toxin service 128
The use of University of Pennsylvania Smell Identification Test in the diagnosis of Parkinson's disease in Italy. 126
Mutation in theSYNJ1Gene Associated with Autosomal Recessive, Early-Onset Parkinsonism 125
Non-motor correlates of smoking habits in de novo Parkinson's disease 125
Comparative cognitive and neuropsychiatric profiles between Parkinson’s disease, multiple system atrophy and progressive supranuclear palsy 125
The contribution of white matter changes to clinical phenotype in progressive supranuclear palsy 124
Orthostatic myoclonus associated with Caspr2 antibodies 124
Comparing PIGD and Akinetic-Rigid subtyping of Parkinson Disease and their stability over time 124
Relationship between apathy and cognitive dysfunctions in de novo untreated Parkinson's disease: a prospective longitudinal study. 123
Clinical use of SAND battery to evaluate language in patients with Progressive Supranuclear Palsy 123
A Screening Tool to Quickly Identify Movement Disorders in Patients with Inborn Errors of Metabolism 119
Segmental progression of cardinal motor symptoms in Parkinson's disease: A pilot study suggesting a practical approach to rate disease course in the early stages. 119
On the relationship between side of onset and cognition in Parkinson disease 119
A novel therapeutic approach for synucleinopathies 118
Uric acid relates to dopamine transporter availability in Parkinson's disease. 117
Gender differences in non-motor symptoms in early, drug naïve Parkinson's disease 117
Insulin-like growth factor-1 and progression of motor symptoms in early, drug-naïve Parkinson's disease. 116
Presence and progression of non-motor symptoms in relation to uric acid inde novoParkinson's disease 116
Clinical clusters and dopaminergic dysfunction in de-novo Parkinson disease 116
Serum epidermal growth factor predicts cognitive functions in early, drug-naive Parkinson's disease patients 115
Midbrain MRI assessments in progressive supranuclear palsy subtypes 113
Brittle response to levodopa as a marker of Parkinson’s disease phenotype characterized by heavy motor and non-motor burden 112
Uncovering clinical and radiological asymmetry in progressive supranuclear palsy—Richardson’s syndrome 109
The PRIAMO study: urinary dysfunction as a marker of disease progression in early Parkinson's disease 108
Abnormal nociceptive processing occurs centrally and not peripherally in pain-free Parkinson disease patients: A study with laser-evoked potentials 108
The "eye of the tiger" sign in pure akinesia with gait freezing. 107
“Atypical” atypical parkinsonism: Critical appraisal of a cohort 107
Genetics of Movement Disorders and the Practicing Clinician; Who and What to Test for? 107
Totale 23.423
Salva come PNG Salva come JPEG
Categoria #
all - tutte 121.676
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 121.676
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.264 0 0 0 9 24 8 17 37 146 164 216 643
2022/20231.556 242 102 73 141 171 371 18 129 202 8 66 33
2023/20241.005 45 132 57 61 46 120 37 77 49 66 55 260
2024/20252.997 84 40 50 121 116 342 372 261 452 422 371 366
2025/202623.529 3.066 5.569 4.716 1.548 1.286 660 2.007 513 619 1.386 377 1.782
2026/20273.279 882 590 1.180 627 0 0 0 0 0 0 0 0
Totale 38.538